TRACER PHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 34090106
Agern Alle 7, 2970 Hørsholm
mhj@tracer-pharma.com
tel: 51301077
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 4 367.23 | 3 967.67 | 3 883.37 | 4 076.39 | 5 412.90 |
| Employee benefit expenses | -3 411.90 | -2 759.55 | -3 552.26 | -3 807.16 | -2 905.86 |
| Other operating expenses | - 257.00 | ||||
| Total depreciation | - 352.28 | - 118.83 | - 121.92 | - 121.92 | -67.44 |
| EBIT | 603.05 | 1 089.30 | 209.19 | 147.30 | 2 182.60 |
| Other financial income | 22.92 | ||||
| Other financial expenses | -19.21 | -22.31 | -23.24 | -21.58 | -19.18 |
| Pre-tax profit | 583.84 | 1 066.99 | 185.95 | 125.72 | 2 186.34 |
| Income taxes | - 128.46 | - 234.74 | -40.91 | -28.77 | - 480.99 |
| Net earnings | 455.38 | 832.25 | 145.04 | 96.95 | 1 705.34 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 284.62 | 351.53 | 229.61 | 107.68 | 40.24 |
| Tangible assets total | 284.62 | 351.53 | 229.61 | 107.68 | 40.24 |
| Investments total | 115.49 | 118.49 | 130.71 | 131.43 | |
| Non-current other receivables | 115.21 | ||||
| Long term receivables total | 115.21 | ||||
| Raw materials and consumables | 263.25 | 203.26 | 235.01 | 177.91 | 71.15 |
| Inventories total | 263.25 | 203.26 | 235.01 | 177.91 | 71.15 |
| Current trade debtors | 184.02 | 1 302.49 | 55.03 | 788.81 | |
| Current amounts owed by group member comp. | 30.66 | 76.44 | 12.13 | ||
| Prepayments and accrued income | 70.15 | 224.06 | 101.23 | 37.58 | 110.88 |
| Current other receivables | 177.16 | 64.48 | 102.22 | 76.34 | 77.33 |
| Current deferred tax assets | 5.08 | 120.55 | 88.75 | 68.36 | |
| Short term receivables total | 467.07 | 1 667.48 | 379.03 | 202.67 | 1 057.50 |
| Cash and bank deposits | 1 397.38 | 912.19 | 2 476.76 | 2 405.96 | 3 361.68 |
| Cash and cash equivalents | 1 397.38 | 912.19 | 2 476.76 | 2 405.96 | 3 361.68 |
| Balance sheet total (assets) | 2 527.52 | 3 249.96 | 3 438.90 | 3 024.93 | 4 662.01 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
| Shares repurchased | 350.00 | 1 000.00 | 1 900.00 | ||
| Retained earnings | 114.33 | 569.71 | 1 051.97 | 197.01 | -1 606.04 |
| Profit of the financial year | 455.38 | 832.25 | 145.04 | 96.95 | 1 705.34 |
| Shareholders equity total | 649.71 | 1 481.96 | 1 627.01 | 1 373.96 | 2 079.30 |
| Provisions | 33.64 | 3.04 | 257.00 | ||
| Non-current other liabilities | 163.85 | ||||
| Non-current deferred tax liabilities | 460.61 | ||||
| Non-current liabilities total | 163.85 | 460.61 | |||
| Advances received | 731.08 | 763.40 | 783.77 | 811.69 | 1 118.52 |
| Current trade creditors | 109.18 | 59.92 | 69.24 | 67.43 | 90.83 |
| Short-term deferred tax liabilities | 215.82 | 196.02 | |||
| Other non-interest bearing current liabilities | 657.87 | 715.00 | 955.85 | 771.84 | 655.75 |
| Current liabilities total | 1 713.96 | 1 734.36 | 1 808.85 | 1 650.97 | 1 865.10 |
| Balance sheet total (liabilities) | 2 527.52 | 3 249.96 | 3 438.90 | 3 024.93 | 4 662.01 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.